The frequent expression of cancer/testis antigens provides opportunities for immunotherapeutic targeting of sarcoma

Cancer immunity

Mahesh Mansukhani¹  Danila Valmori²  Mary-Louise Keohan³  Hanina Hibshoosh¹  Lorenzo Memeo¹  Genevieve Metthez²  Maha Ayyoub²  Robert N. Taub³  Charles S. Hesdorffer³  Mary Hesdorffer³ 

[1] Department of Pathology, Columbia University College of Physicians and Surgeons, New York, NY, USADepartment of Pathology, Columbia University College of Physicians and Surgeons, New York, NY, USADepartment of Pathology, Columbia University College of Physicians and Surgeons, New York, NY, USA;Ludwig Institute Clinical Trial Center, Division of Medical Oncology, Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY, USALudwig Institute Clinical Trial Center, Division of Medical Oncology, Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY, USALudwig Institute Clinical Trial Center, Division of Medical Oncology, Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY, USA;Division of Medical Oncology, Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY, USADivision of Medical Oncology, Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY, USADivision of Medical Oncology, Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY, USA

关键词: human;    sarcoma;    cancer/testis;    tumor antigens;    gene expression;   

DOI  :  

学科分类：肿瘤学

来源: Cancer immunity

【 授权许可】

Unknown